We are pleased to announce the publication of our latest SureChEMBL paper, " SureChEMBL in 2026: an open database of chemical and biomedical annotations from the patent literature ", in Nucleic Acids Research . The paper presents a major redesign of SureChEMBL , including modernised infrastructure, improved chemical extraction and standardisation workflows, and new biomedical annotations that connect patent chemistry to genes, proteins, diseases and mechanisms. The updated resource provides open access to 122 million patents, 44 million chemically annotated documents, 31 million chemical structures and 1 million biomedical entity annotations. Abstract The patent literature is a major source of scientific and technical information for drug discovery, often disclosing chemical structures, biological targets, therapeutic indications, and structure-activity relationships before they appear in the scientific literature. However, patent documents are difficult to analyse at scale b...
Blog of Chemical Biology Resources at EMBL-EBI